Evaluating Newly Approved Drugs for Multidrug-resistant TB

Clinical trial NCT02754765 · COMPLETED

Trial details

NCT number: NCT02754765
Sponsor: Médecins Sans Frontières, France
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant Infection, Bacterial Pulmonary Tuberculoses

Start date: 2016-12-01
Primary completion: 2023-06-01
Enrollment: 754

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.